<p><strong>🎤Amanda Guiraldelli Mahr&nbsp;</strong></p><p><strong>Amanda shares insights from her work across small molecules, peptides, proteins, and biopharmaceuticals, including her experience with LC-MS, metabolomics, impurity analysis, and oligonucleotide therapeutics.</strong></p><h4><strong>What You’ll Learn in This Episode:</strong></h4><ul><li>What AQbD actually means (in simple terms)</li><li>How DOE differs from traditional one-factor-at-a-time experiments</li><li>Why modern labs are shifting toward predictive, data-driven method development</li><li>The biggest benefits of DOE: more insight with fewer experiments*</li><li>Real-world example: optimizing oligonucleotide impurity separations using AQbD&nbsp;</li><li>Key LC parameters that impact performance (pH, gradient, column, temperature)</li><li>Challenges of working with large molecules vs. small molecules</li><li>Tools and software for DOE and chromatographic modeling</li><li>How AI and modeling are shaping the future of chromatography</li></ul><blockquote><p><strong>Key Takeaway: </strong>“Shift your mindset from testing to understanding.”</p></blockquote><h4><strong>Who This Episode Is For:</strong></h4><ul><li>Undergraduate and graduate chemistry students</li><li>Analytical scientists and method developers</li><li>Pharma &amp; biopharma professionals</li><li>Anyone working with LC, LC-MS, or chromatography method development</li></ul><h3><strong>Video Transcription</strong></h3><p>In this episode of <i>Concentrating on Chromatography</i>, David interviews <strong>Amanda Guiraldelli Mahr</strong>, an analytical chemist whose career has spanned pharmaceuticals, metabolomics, regulatory science, mass spectrometry, and biopharmaceutical analysis. Amanda discusses her journey from pharmacy and biochemistry studies to working with chromatography and mass spectrometry in academic, regulatory, and industrial environments.</p><p>The conversation focuses on the growing role of <strong>Analytical Quality by Design (AQbD)</strong>, <strong>Design of Experiments (DOE)</strong>, predictive modeling, and the future integration of artificial intelligence into chromatographic method development. Amanda also shares practical insights into method development for small molecules, peptides, proteins, oligonucleotides, and emerging therapeutics.</p><h4><strong>Early Career and Introduction to Chromatography</strong></h4><p>Amanda's interest in analytical chemistry began during her studies in pharmacy and biochemistry. An internship focused on chromatography for botanical medicine analysis introduced her to separation science and inspired her to pursue a PhD in analytical chemistry.</p><p>During her doctoral research, she worked extensively with <strong>LC-MS-based metabolomics</strong>, which led her to explore experimental design approaches and method development strategies. Her passion for chromatography and mass spectrometry deepened further while working at the United States Pharmacopeia (USP), where she routinely applied chromatographic and mass spectrometric techniques to characterize:</p><ul><li>Small-molecule drug substances</li><li>Pharmaceutical ingredients</li><li>Dietary supplements</li><li>Botanical products</li><li>Peptides</li><li>Proteins</li></ul><p>Her work increasingly involved understanding chromatographic separation mechanisms through experimental design and modeling approaches.</p><h4><strong>Expanding into Proteomics, Nitrosamines, and Biopharmaceuticals</strong></h4><p>Amanda's scientific curiosity led her beyond traditional small-molecule analysis.</p><p>Throughout her career she gained experience in:</p><ul><li>High-resolution mass spectrometry</li><li>Structural elucidation</li><li>Proteomics</li><li>Bioanalysis</li><li>Trace impurity analysis</li><li>Nitrosamine monitoring</li><li>Oligonucleotide therapeutics</li><li>Large proteins and peptides</li></ul><p>She worked with advanced fragmentation techniques including:</p><ul><li>CID (Collision-Induced Dissociation)</li><li>HCD (Higher-Energy Collisional Dissociation)</li><li>UV Photodissociation</li></ul><p>Later, she became involved in developing highly sensitive LC-MS and GC-MS methods for monitoring <strong>nitrosamines</strong>, a major regulatory concern due to their genotoxic potential. She also trained regulatory agencies in mass spectrometry applications and method validation before moving into biopharmaceutical research and contract research activities focused on proteins, peptides, oligonucleotides, and RNA therapeutics.</p><h4><strong>What Does a Chromatographer Do Every Day?</strong></h4><p>When asked to summarize the day-to-day work of a chromatographer, Amanda highlighted three core activities:</p><ul><li>Designing experiments</li><li>Troubleshooting analytical methods</li><li>Interpreting unexpected results</li></ul><p>She emphasized that a large portion of her work involves data analysis and learning from experimental outcomes in order to optimize methods and better understand chromatographic behavior.</p><h4><strong>Understanding Analytical Quality by Design (AQbD)</strong></h4><p>One of the central topics of the discussion was <strong>Analytical Quality by Design (AQbD)</strong>.</p><p>Amanda describes AQbD as a systematic approach for understanding how analytical methods perform and identifying factors that influence method variability.</p><p>Key objectives of AQbD include:</p><ul><li>Identifying critical method parameters</li><li>Understanding sources of variability</li><li>Building robustness into methods from the beginning</li><li>Improving method reliability throughout its lifecycle</li></ul><p>Rather than correcting problems after implementation, AQbD focuses on proactively designing analytical procedures that consistently deliver high-quality results.</p><p>Amanda noted that AQbD principles are strongly linked to pharmaceutical quality frameworks established through ICH guidelines such as:</p><ul><li>ICH Q8 (Pharmaceutical Development)</li><li>ICH Q14 (Analytical Procedure Development)</li></ul><p>These guidelines have significantly influenced modern pharmaceutical method development practices.</p><h4><strong>AQbD vs. Traditional Trial-and-Error Development</strong></h4><p>Amanda contrasted AQbD with the traditional <strong>one-factor-at-a-time (OFAT)</strong> approach.</p><h5><strong>Traditional Approach</strong></h5><ul><li>Changes one parameter at a time</li><li>Provides limited understanding of interactions</li><li>Often misses important relationships between variables</li></ul><h5><strong>AQbD Approach</strong></h5><ul><li>Uses multivariate experimental designs</li><li>Studies multiple variables simultaneously</li><li>Reveals interactions between parameters</li><li>Enables predictive modeling</li><li>Defines robust operating ranges</li></ul><p>According to Amanda, AQbD provides significantly more knowledge about method behavior while reducing unnecessary experimentation.</p><h4><strong>Design of Experiments (DOE): A Core AQbD Tool</strong></h4><p>Amanda clarified an important misconception:</p><p><strong>DOE is not the same as AQbD.</strong></p><p>Instead:</p><ul><li>AQbD is a broader philosophy and lifecycle approach.</li><li>DOE is one of the most powerful tools used within AQbD.</li></ul><p>DOE helps scientists:</p><ul><li>Identify critical factors</li><li>Evaluate interactions</li><li>Map regions of good and poor performance</li><li>Support risk assessment</li><li>Build predictive models</li></ul><p>However, AQbD also includes risk management, control strategies, and lifecycle monitoring beyond experimental design itself.</p><h4><strong>Practical Advice for Scientists New to DOE</strong></h4><p>For scientists interested in implementing DOE, Amanda recommends starting with simple screening studies.</p><p>Examples include evaluating:</p><ul><li>LC column chemistry</li><li>Mobile-phase pH</li><li>Organic modifiers</li><li>Temperature</li></ul><p>Important responses to monitor may include:</p><ul><li>Resolution</li><li>Peak tailing</li><li>Selectivity</li><li>Efficiency</li></ul><p>She encourages scientists to focus not only on collecting data but on understanding the patterns revealed by experimental results. As experience grows, more advanced optimization studies and predictive models can be developed.</p><h4><strong>Which LC Parameters Matter Most?</strong></h4><p>Amanda emphasized that critical parameters depend on:</p><ul><li>Sample type</li><li>Separation mode</li><li>Intended method purpose</li><li>Development stage</li></ul><p>For reversed-phase LC, common screening parameters include:</p><ul><li>Column chemistry</li><li>Mobile-phase pH</li><li>Organic solvent composition</li><li>Temperature</li></ul><p>For ion-pair chromatography, additional factors such as:</p><ul><li>Ion-pairing reagent type</li><li>Ion-pairing reagent concentration</li></ul><p>can strongly influence selectivity and retention behavior.</p><p>She stresses that proper risk assessment should always guide parameter selection.</p><h4><strong>Case Study: Oligonucleotide Impurity Profiling</strong></h4><p>Amanda shared an example involving impurity analysis of <strong>oligonucleotide therapeutics</strong>.</p><p>One major challenge is that impurities are often structurally very similar to the active pharmaceutical ingredient (API), making chromatographic separation difficult.</p><p>Using AQbD and DOE, her team systematically evaluated:</p><ul><li>LC column chemistries</li><li>Ion-pairing reagents</li><li>Temperature</li><li>Gradient conditions</li></ul><p>A desirability-function approach allowed simultaneous optimization of multiple critical resolutions rather than focusing on a single impurity pair.</p><p>This strategy enabled the development of an LC-UV method capable of separating impurities that might otherwise require LC-MS for quantification.</p><h4><strong>The Challenges of Large Molecules</strong></h4><p>Amanda identifies large biomolecules as some of the most challenging analytes in chromatography.</p><p>Compared with small molecules, proteins and oligonucleotides exhibit:</p><ul><li>Slower mass transfer kinetics</li><li>Peak broadening</li><li>Reduced sensitivity</li><li>Greater sensitivity to system-related factors</li></ul><p>Even seemingly minor differences can affect performance, including:</p><ul><li>Dwell volume</li><li>Tubing dimensions</li><li>System dispersion</li></ul><p>She also highlighted non-specific adsorption as a major challenge.</p><p>Examples include:</p><h5><strong>Oligonucleotides</strong></h5><p>Negatively charged phosphate backbones can interact strongly with metal surfaces, reducing recovery and reproducibility.</p><h5><strong>Peptides</strong></h5><p>Basic amino acid residues may interact with residual silanol groups on silica-based stationary phases, affecting chromatographic performance.</p><p>These challenges have driven innovation in:</p><ul><li>Low-adsorption LC systems</li><li>Surface-modified columns</li><li>Hybrid particle technologies</li><li>Improved consumables and hardware design</li></ul><h4><strong>Software and Modeling Tools</strong></h4><p>Amanda discussed several software platforms commonly used for DOE and method optimization:</p><h5><strong>DOE Software</strong></h5><ul><li>Design-Expert</li><li>JMP</li><li>Minitab</li><li>MODDE</li></ul><h5><strong>Chromatographic Modeling Software</strong></h5><ul><li>DryLab</li><li>ACD/AutoChrom</li><li>ChromSword</li></ul><p>She also noted that modern software increasingly integrates directly with chromatographic data systems, enabling automated experiment execution and data analysis.</p><h4><strong>Essential Skills Beyond Instrument Operation</strong></h4><p>According to Amanda, successful chromatographers need more than technical instrument expertise.</p><p>Key skills include:</p><ul><li>Chromatographic fundamentals</li><li>Statistics</li><li>Chemometrics</li><li>Data interpretation</li><li>Predictive modeling</li><li>Risk assessment</li></ul><p>She emphasized that statistical literacy is particularly important for implementing AQbD principles and validating predictive models.</p><h4><strong>The Future of Chromatography</strong></h4><p>Looking ahead, Amanda is particularly excited about the integration of:</p><ul><li>Artificial intelligence</li><li>Predictive modeling</li><li>Knowledge-driven method development</li></ul><p>She believes these technologies will help scientists better understand separation mechanisms and accelerate development of methods for increasingly complex therapeutics.</p><p>Ultimately, she expects analytical science to play an even more central role in pharmaceutical development, manufacturing, and quality assurance.</p><h4><strong>Conclusion</strong></h4><p>Amanda's career illustrates how chromatography has evolved from traditional small-molecule analysis into a highly interdisciplinary field spanning proteomics, biopharmaceuticals, oligonucleotide therapeutics, and advanced regulatory science. Her experience demonstrates the value of combining chromatographic expertise with AQbD principles, DOE, risk assessment, and predictive modeling.</p><p>As analytical challenges continue to grow in complexity, approaches that emphasize understanding, prediction, and quality by design are becoming increasingly important. The future of chromatography is likely to be shaped by data-driven decision making, advanced modeling, and artificial intelligence—tools that will enable scientists to develop more robust, efficient, and reliable analytical methods.</p><blockquote><p><strong>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</strong></p></blockquote><blockquote><h4><strong>Concentrating on Chromatography Podcast</strong></h4><p>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!</p><p>You can find <strong>Concentrating on Chromatography Podcast </strong>in podcast apps:</p><ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL"><strong>Spotify</strong></a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185"><strong>Apple podcast</strong></a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography"><strong>podscan</strong></a></li></ul><p>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos"><strong>YouTube channel</strong></a></p></blockquote>

AQbD Explained: How Design of Experiments is Transforming Chromatography

Untargeted Metabolomics Identifies N-Lactoyl-Amino Acids as Dose-Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes

<p><strong>In the week of June 22, the following webinars await you in the field of liquid phase and especially HPLC and LC/MS.</strong></p><blockquote><h4><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinars"><strong>👉 DETAILS AND REGISTRATION IN THE WEBINARS SECTION</strong></a></h4><p><strong>👉 Search and filter in the largest global database</strong> with over <strong>5 500 GC, LC, MS and spectroscopy webinars</strong>.</p></blockquote><h5><strong>1. Thermo Fisher Scientific: Simplifying Complexity in GLP-1 Receptor Agonist Analysis: From Structural Characterization to Impurity Monitoring</strong></h5><ul><li>Tu, 23.6.2026 15:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6275">Registration</a></li></ul><p>Simplify GLP-1 receptor agonist analysis. Learn how a streamlined LC-MS workflow combines UHPLC and high-resolution MS for peptide characterization and impurity monitoring.</p><h5><strong>2. Tosoh Bioscience: Tosoh Tuesday - Exploring the AAV Toolkit</strong></h5><ul><li>Tu, 23.6.2026 15:45 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6273">Registration</a></li></ul><p>Improve AAV analysis and purification. Learn how to increase recovery and purity using the TOYOPEARL GigaCap Q-650S resin and columns from Tosoh Bioscience.</p><h5><strong>3. Phenomenex: Sustainable Strategies for High Sensitivity Analysis for Clinical Research LC-MS/MS Methods</strong></h5><ul><li>We, 24.6.2026 10:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6278">Registration</a></li></ul><p>Optimize clinical LC-MS/MS methods using sustainable ethyl acetate SLE to extract steroids, MMA, and estrogens from human serum with high recovery.</p><h5><strong>4. Agilent Technologies: Preparing for LC Analysis: What to Consider Ahead of Time</strong></h5><ul><li>We, 24.6.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6288">Registration</a></li></ul><p>Avoid chromatography problems before they start. Learn how to prepare sample matrices, select and maintain LC columns, and establish an effective system housekeeping list.</p><h5><strong>5. SelectScience: Next-generation metabolomics: From annotation to discovery at scale</strong></h5><ul><li>We, 24.6.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6281">Registration</a></li></ul><p>Explore how next-generation mass spectrometry, ion mobility, and advanced computational tools accelerate confident small-molecule annotation and discovery in metabolomics.</p><h5><strong>6. Waters Corporation: Clear the Noise: Improving Resolution of GLP-1 Receptor Agonist and Insulin Impurities</strong></h5><ul><li>We, 24.6.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6262">Registration</a></li></ul><p>Learn how to gain greater resolution for your GLP-1 RA and insulin impurity analysis separations.</p><h5><strong>7. Shimadzu Corporation: Meet LCMS-8065XE: Achieving High-Throughput Ultra-Trace Analysis</strong></h5><ul><li>Th, 25.6.2026 08:30 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6290">Registration</a></li></ul><p>In this webinar, we will analyze real-world performance data demonstrating how LCMS-8065XE enables high sensitivity analysis even in complex matrices.</p><h5><strong>8. Waters Corporation: Creating Better Chromatographic Methods Using a Systematic Approach</strong></h5><ul><li>Th, 25.6.2026 10:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6284">Registration</a></li></ul><p>Stop guessing and start separating. Learn a structured, systematic approach to LC method development to improve robustness and accelerate column selection.</p><h5><strong>9. Waters Corporation: Lower the Flow to see even more</strong></h5><ul><li>Th, 25.6.2026 15:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6285">Registration</a></li></ul><p>Boost large molecule sensitivity in bioanalysis. Learn how switching to microflow LC-MS/MS improves limits of quantification, cuts costs, and reduces solvent usage.</p><h5><strong>10. Separation Science: Advancing PFAS Analysis: From Hidden Precursors to Food Safety Workflows</strong></h5><ul><li>Th, 25.6.2026 16:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6286">Registration</a></li></ul><p>Discover practical approaches for detecting, analyzing, and addressing PFAS contamination in environmental and food-related samples.</p><h5><strong>11. Waters Corporation: Achieving Accurate BOD Results: What Your Questions Revealed</strong></h5><ul><li>Th, 25.6.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6283">Registration</a></li></ul><p>Get consistent and defensible BOD results by learning how to troubleshoot common testing errors and standardize your laboratory procedures.</p><h5><strong>12. SelectScience: Future-ready biobanking starts with smarter sample storage</strong></h5><ul><li>Fr, 26.6.2026 16:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6289">Registration</a></li></ul><p>Safeguard your specimens in biobanking and clinical research. Learn from Thermo Fisher Scientific experts how to optimize sample storage, traceability, and compliance.</p><h5><strong>13. SelectScience: Enhancing Empower software data with cloud-based applications</strong></h5><ul><li>Fr, 26.6.2026 17:30 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6287">Registration</a></li></ul><p>Connect your chromatography data with Waters’ new cloud-based software solutions. Learn how to track system status in real time and enable AI-powered data analytics.</p>

Webinars LabRulezLCMS Week 26/2026

Article

Webinars

Video

Scientists

Scientific article

Interview

Science and research

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Current Trends in Seized Drug Analysis Symposium (2026)

Bruker at Current Trends in Seized Drug Analysis Symposium

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Columbia - MD

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Milford, MA

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Pleasanton, CA

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Morrisville, NC

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Costa Mesa, CA

Comprehensive Biotherapeutic Analysis: Characterization of ADCs, AOCs, mAbs, and Peptides with Waters Chemistry, LC, MS, and MALS Solutions

ASMS: 2nd Winter Conference

Upcoming events from the LCMS area

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Costa Mesa, CA

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Morrisville, NC

Comprehensive Biotherapeutic Analysis: Characterization of ADCs, AOCs, mAbs, and Peptides with Waters Chemistry, LC, MS, and MALS Solutions

Comprehensive Biotherapeutic Analysis: Characterization of ADCs, AOCs, mAbs, and Peptides with Waters Chemistry, LC, MS, and MALS Solutions

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Pleasanton, CA

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Milford, MA

ASMS: 2nd Winter Conference

Bruker at Current Trends in Seized Drug Analysis Symposium

Current Trends in Seized Drug Analysis Symposium (2026)

Beyond Reverse Phase: Innovative Separation Strategies for Complex Separations, Columbia - MD

Related content

Webinars LabRulezLCMS Week 26/2026

Untargeted Metabolomics Identifies N-Lactoyl-Amino Acids as Dose-Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes

AQbD Explained: How Design of Experiments is Transforming Chromatography